Aprea Therapeutics (APRE) EBITDA (2022 - 2026)
Aprea Therapeutics' EBITDA came in at -$4.03 million for Q2 2026, compared with -$3.38 million a year earlier.
Powered by 
Analysis
Aprea Therapeutics (APRE) EBITDA (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aprea Therapeutics reported EBITDA of -$13.2 million; for FY2025, it came in at -$13.21 million.
- Going back by year, EBITDA was -$14.3 million in FY2024, -$15.46 million in FY2023, -$113.39 million in FY2022 and -$37.43 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBITDA since Q1 2025.
- Business Quant data shows APRE's EBITDA at -$3.42 million (Q1 2026), -$2.64 million (Q4 2025) and -$3.11 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Aprea Therapeutics | 28.18 Mn | -87.88 Mn | - | -4.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.03 Mn |
| Mar 31, 2026 | -3.42 Mn |
| Dec 31, 2025 | -2.64 Mn |
| Sep 30, 2025 | -3.11 Mn |
| Jun 30, 2025 | -3.38 Mn |
| Mar 31, 2025 | -4.08 Mn |
| Dec 31, 2024 | -3.22 Mn |
| Sep 30, 2024 | -4.09 Mn |
| Jun 30, 2024 | -3.84 Mn |
| Mar 31, 2024 | -3.14 Mn |
| Dec 31, 2023 | -3.67 Mn |
| Sep 30, 2023 | -3.52 Mn |
| Jun 30, 2023 | -3.65 Mn |
| Mar 31, 2023 | -4.62 Mn |
| Dec 31, 2022 | -2.65 Mn |
| Sep 30, 2022 | -4.20 Mn |
| Jun 30, 2022 | -98.46 Mn |
API Access
Aprea Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=APRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();